☰

Biofaktor Sp. z o.o.

Connecting two plants into one queryable process view

Industry
Pharmaceutical Manufacturing
Headquarters
Skierniewice, Poland
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Biofaktor Sp. z o.o.'s published strategy and is not endorsed by, or produced in cooperation with, Biofaktor Sp. z o.o.. Company website

Strategic priorities

Biofaktor Sp. z o.o. operates two Polish manufacturing sites — a Skierniewice facility certified to GMP, HACCP, ISO 9001:2015 and EN ISO 13485:2016 for human pharmaceuticals and medical devices, and a larger Gorzów Wielkopolski site focused on veterinary medicines, animal feed and dietary supplements. Across both sites the company's stated objective is the same: position itself as a contract development and manufacturing partner for international sponsors in EMEA (Europe, Middle East and Africa) and East Asia, anchored on its appearance at VIV Select Turkiye 2025 and EuroTier 2024.

The active programme that most directly tests that ambition is the in-flight technology transfer of a laryngological drug recipe from an external development firm onto Biofaktor's own production lines, disclosed in the 2023 financial statements. Migrating recipe parameters from an external laboratory to industrial-scale mixing and filling equipment is the part of the operation where data integrity has the largest effect on batch outcome, and it is currently run with manual transcription between systems.

The funding path for that work is in place: Polish EU programmes under the FENG 2021-2027 framework, including Dig.IT and the Automation and Robotization in SMEs call, fund up to 3,000,000 PLN at 85 percent of eligible cost for Industry 4.0 investments at mid-sized manufacturers. Biofaktor's stated strategic direction — from "Biotech" to "TechBio" — is eligible for that support before any internal capital is committed.

What sits between the subsidy window and the international ambitions is the connective layer: equipment from different vendors in different Polish cities, generating data in different shapes, with no shared model across the manufacturing cycle. Each of the five challenges below is a facet of that same underlying gap.

Challenges we see

  • Digital Manufacturing

    Reading process data from legacy equipment on the shop floor

    Biofaktor's two production sites run a mix of equipment from different vendors, with much of the day-to-day process information recorded by hand rather than captured by the equipment that produced it. The Skierniewice plant is certified to GMP, HACCP, ISO 9001:2015 and EN ISO 13485:2016, which means the data behind a batch record is also the data a regulator is asked to trust.

    Where process values live on a paper sheet or in a controller's local memory, the population the quality organisation reviews is the whole batch. Capturing those values at the equipment turns the same review into a check on the units that actually deviated.

  • Operations Integration

    Moving a recipe from an external developer to a production line without losing parameters

    The 2023 financial statements describe a technology transfer in progress, with Biofaktor collaborating with an external firm on a laryngological drug recipe and preparing to migrate it to its own technological line. The destination is industrial-scale mixing and filling equipment whose chiller and agitator performance is set against the parameters developed in the external lab.

    When a recipe moves between two organisations, the handover is the part of the lifecycle where any parameter that is not explicitly named has a habit of being approximated. A shared model for the parameters turns that handover into a query against one record rather than a comparison between two.

  • Digital Integration

    Bridging equipment from different vendors into one production view

    Laboratory and production assets at both Skierniewice and Gorzów Wielkopolski come from multiple vendors, each with their own communication protocols. The two sites operate as separate plants with their own quality systems and their own data paths.

    Where every vendor's equipment speaks a different protocol, even a small change to a recipe is an integration project. Agreeing on one transport standard and one information model before the next equipment purchase makes the next change a configuration rather than a development.

  • Operations Operations

    Holding on to operational knowledge as people change roles

    The Skierniewice and Gorzów sites run long-tenured production equipment whose safe operation depends on know-how that lives with the operators who use it. Polish CDMOs and manufacturers report a market in which experienced operators move between employers, and the cost of an operator leaving is paid in the time it takes the next one to learn the line.

    When a procedure lives in someone's head, the procedure leaves with them. The same procedure written down and tied to the equipment that runs it stays in the plant.

  • Compliance Regulatory

    Protecting client recipe data across an internationally connected estate

    Biofaktor is positioning to win contract manufacturing work from international sponsors, and its international ambition runs alongside a control estate that includes legacy programmable logic controllers and perimeter-based network design. The CDMO service proposition rests on the assumption that proprietary client recipes are protected at the same level as Biofaktor's own.

    Where the same network carries shop-floor traffic and remote-audit access, the audit path and the attack path are the same path. Separating them by design rather than by policy is what makes a remote audit possible without giving that audit reach into the recipe.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Streaming process data off legacy equipment into a shared view

    Process information at both Biofaktor sites is largely captured by hand, with each vendor's equipment speaking its own protocol. Operators work from controllers and logbooks, and the data needed to confirm a batch's behaviour sits in more places than the quality organisation can readily join up.

    Adding sensors and a documented transport layer to the existing equipment, and presenting the resulting values in a view that mirrors the plant's process diagrams, gives operators, quality and engineering the same picture of what the line is doing while the batch is still on it.

    • Biofaktor, Quality mission, vision of the future, biofaktor.pl/en
    • Biofaktor Sp Zo.o, PharmaSource company profile
    • A4BEE, Transforming Raw Bioprocess Data into Actionable Insights (case study)

  2. Capturing the laryngological tech transfer as data, not transcription

    The active technology transfer for the laryngological drug recipe described in the 2023 financial statements depends on parameters being copied between an external development environment and Biofaktor's production line. The destination equipment, including chiller and mixing systems, is set against those parameters and the transfer has to be reproducible across batches.

    A shared, machine-readable model for the recipe parameters, with a single chain of custody from the external developer to the production batch record, replaces handwritten handover with a query against one record. The audit trail the regulator asks for is the audit trail the system already keeps.

    • Biofaktor Sp. z o.o., 2023 financial statements, rejestr.io KRS 0000054091
    • A4BEE, Ontology-driven ecosystem for bio-manufacturing data (case study)

  3. Designing the next equipment purchase so it is interoperable by default

    Both Skierniewice and Gorzów house equipment from several vendors, and the integration cost of any new recipe is paid in engineering hours. Future capital expenditure — including the equipment that will run the laryngological recipe at scale — repeats the same integration project unless the procurement language is changed.

    Writing OPC UA (Open Platform Communications Unified Architecture) information models and a documented reference architecture into the procurement requirements before the next equipment order means the equipment that arrives on site is interoperable from day one, rather than after a custom integration project.

    • A4BEE, MTP library for modular automation (case study)
    • A4BEE, Strategic integration guides for pharmaceutical control systems (case study)

  4. Keeping operational knowledge attached to the plant, not the shift

    The two Biofaktor sites depend on operators who know the idiosyncrasies of long-tenured equipment. As those operators move on, the next person to run the line relearns it from scratch, and the period between operators is the period of highest quality and safety risk on the line.

    Capturing procedures, decision points and known failure modes against the equipment they apply to, in a form a new operator can read at the workstation, makes the plant's know-how a property of the plant rather than of the people on shift.

    • A4BEE, Support framework and assisted reality for global biotech manufacturer (case study)
    • A4BEE, UX in life science (article)

  5. Separating the audit path from the attack path on the plant network

    As Biofaktor's CDMO proposition extends to international sponsors, remote audit access and client data review become part of the service offering. The current estate combines legacy programmable logic controllers with perimeter-based network design, which makes remote access hard to grant safely.

    An IEC 62443-aligned network design with explicit zones and conduits, and an identity-based access model in line with NIS2 expectations, lets the same site host a remote audit and protect a proprietary recipe without one compromising the other.

    • A4BEE, Zero Trust security principles (article)
    • A4BEE, Strategic integration guides for pharmaceutical control systems (case study)

What we'd propose

  • Digital CDMO

    Real-time process visibility across both Biofaktor sites

    We bring process data off the existing equipment at Skierniewice and Gorzów Wielkopolski into a single time-series model and present it in a view that mirrors the plant's process diagrams, so operators, quality and engineering read the line the same way during a batch.

    • Data acquisition from existing equipment

      Process data off legacy kit

      Add sensors and documented transport to chillers, mixers, scales and inspection stations that currently run in isolation, so process values leave the equipment in a documented, vendor-neutral form rather than staying inside a closed controller.

    • Process-diagram-aligned dashboards

      One view that mirrors the plant

      Design the operator view to mirror the physical Process & Instrumentation Diagrams, so the screen the operator looks at is the screen the procedure refers to, and the data behind it is the data the equipment produced.

    • Tiered alerting against a current batch

      Notifications on what matters now

      Categorise alerts by severity and against the batch that is currently running, so the operator's attention goes to the deviation that needs it rather than to the noise that surrounds it.

    • Operators, quality and engineering read the same picture of a running batch, on the same screen, from the same data.
    • The data that confirms a batch's behaviour is captured at the equipment, not transcribed from it after the fact.
    • Deviations surface against the batch in progress, in time to act on them.

    We've done this before

    See how we do Digital CDMO
  • Enterprise AI

    A shared data model for the laryngological technology transfer

    An ontology-based data platform that defines the parameters of the laryngological recipe once, then carries them from the external developer through scale-up to the production batch record, so the same parameters describe the recipe in every system the transfer touches.

    • Recipe parameter ontology

      One agreed set of terms

      Define the recipe's parameters, their units and the relationships between them as explicit entities in a shared model, so a parameter named in the external lab is the same parameter named in the production batch record.

    • Pipeline from the external developer to the production line

      Parameters move as data

      Build the data path from the external development environment into Biofaktor's production systems, with validation at the boundary so a parameter that arrives malformed is rejected at the door rather than carried into the batch.

    • Scale-up comparison against the production batch

      Pilot numbers next to plant numbers

      Place the pilot-scale parameters alongside the production-scale results in the same view, so the non-linear behaviour of scale-up (heat transfer at 500 litres rather than at 50 litres, for example) is visible to the engineer who has to set the next batch.

    • The recipe's parameters have one home, named the same way in every system the transfer touches.
    • The handover from the external developer becomes a query against one record, not a comparison between two.
    • The audit trail the regulator asks for is the audit trail the system already keeps.

    We've done this before

    See how we do Enterprise AI
  • Digital CDMO

    Modular production standards for the next equipment purchase

    A reference architecture and equipment-procurement standards, built around OPC UA and the MTP (Module Type Package) standard, agreed before the next production asset is ordered, so the equipment that arrives at Skierniewice or Gorzów is interoperable from day one.

    • Reference architecture for both sites

      One documented data path

      Specify how production equipment, line supervision and enterprise systems connect, including the segmentation model, so every vendor on the project builds toward the same target rather than toward their own default.

    • Equipment data contracts in the procurement language

      What each machine must publish

      Write the OPC UA information models and MTP service descriptions into the procurement requirements, making interoperability a purchase condition rather than an integration project after the equipment is installed.

    • Variable batch sizing by configuration, not by reprogramming

      Same recipe, different vessel size

      Enable the production lines to move from a 50-litre pilot batch to a 500-litre commercial batch by reconfiguring the same module descriptions, so each new product and each scale change is a configuration task rather than an engineering project.

    • The next equipment order arrives ready to talk to the systems it has to talk to.
    • A new product or a new batch size is a configuration of the same modules, not a new project.
    • The same architecture and procurement language is reusable as both sites are upgraded.

    We've done this before

    See how we do Digital CDMO
  • Digital CDMO

    Cybersecurity architecture fit for an international CDMO service

    A plant network designed to IEC 62443 with explicit zones, conduits and identity-based access, so the same site can host a remote audit from an international sponsor and protect a proprietary client recipe without one compromising the other.

    • Network segmentation to IEC 62443

      Zones and conduits from day one

      Define the security zones and the conduits between them before the next control system is connected, so the plant's security posture is set by design and is not re-argued against a live production line.

    • Identity-based access for the audit path

      Who can see what, verified each time

      Replace perimeter-based trust with an identity- and device-aware access model for every connection into the plant network, including remote audit sessions, so the audit path is verified each time it is used.

    • Anomaly visibility for the control estate

      Behaviour, not just signatures

      Provide monitoring of the control network that distinguishes between a sensor behaving oddly and an attacker moving laterally, so the response the team takes is the response the situation calls for.

    • International sponsors can audit the site remotely without that access becoming a path to the recipe.
    • The plant network's security posture is a property of the design, not a policy bolted on afterwards.
    • The same architecture satisfies the NIS2 expectations that increasingly apply to mid-sized European manufacturers.

    We've done this before

    See how we do Digital CDMO

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what Biofaktor Sp. z o.o.'s own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data acquisition 25 → 80
Both Polish sites rely on manual data entry alongside vendor-specific control systems, and the in-flight laryngological transfer makes the gap between manual capture and equipment-native capture directly visible. The target state is automated acquisition into a shared model.
Process visibility 20 → 85
The current operator view is a mix of legacy supervisory screens and paper, with no shared KPIs (key performance indicators) across the two sites. The target is a single time-series model with views aligned to the plant's own process diagrams.
Production modularity 30 → 75
Each new product and each new batch size is currently an integration project rather than a configuration. OPC UA and MTP-based equipment procurement is the path to treating production modules as interchangeable building blocks.
Workforce enablement 25 → 70
Operational know-how is held by the operators currently on shift, and the period between operators is the period of highest quality and safety risk. Capturing procedures against the equipment is the path to a plant whose know-how is its own property.
Cybersecurity posture 35 → 85
The current estate combines legacy programmable logic controllers with perimeter-based network design, which is incompatible with international CDMO service expectations. The target is IEC 62443-aligned zones and conduits with identity-based access.
IT/OT convergence 30 → 80
The two sites operate as separate plants with separate data paths and separate quality systems. The target is one documented data path per site, with shared semantics between the two so a query against one is a query against both.

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Biofaktor Sp. z o.o., and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].